To test new TSPO tracers, stroke models present the advantages of being clinically relevant and to induce a strong TSPO+ microglial activation that has been demonstrated both preclinically [8, 11] and clinically [57, 58, 60]. This evidence concerns the gene TSPO and stroke disorder.